All Issue

2024 Vol.5, Issue 2 Preview Page

Review article

30 June 2024. pp. 49-52
Abstract
Sorry, not available.
Click the PDF button.
References
1

Baillargeon J et al., The association of body mass index and prostate-specific antigen in a population-based study, Cancer, 2005

10.1002/cncr.2085615668913
2

Hamilton RJ et al., The influence of statin medications on prostate-specific antigen levels, J Natl Cancer Inst, 2008

10.1093/jnci/djn36218957682
4

Smith AB et al., Finasteride in the treatment of patients with benign prostatic hyperplasia: a review, Ther Clin Risk Manag, 2009

5

Finasteride - StatPearls - NCBI Bookshelf (website: https://www.ncbi.nlm.nih.gov/books/NBK513329/)

6

Kaplan SA et al., PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: Preliminary study, Urology, 2002

10.1016/S0090-4295(02)01760-012350485
7

Andriole GL et al., Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride, J Urol, 2006

10.1016/S0022-5347(05)00984-516600723
8

Marks LS et al., The interpretation of serum prostate specific antigen in men receiving 5a-reductase inhibitors: A review and clinical recommendations, J Urol, 2006

10.1016/j.juro.2006.04.02416890642
9

Kulkarni GS et al., Evidence for a biopsy derived grade artifact among larger prostate glands, J Urol, 2006

10.1016/S0022-5347(05)00236-316406982
10

McClellan KJ et al., Finasteride: a review of its use in male pattern hair loss, Drugs, 1999

10.2165/00003495-199957010-000149951956
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 5
  • No :2
  • Pages :49-52